Clinical Trial Update: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. [Phase 1]

View source ↗

Summary

Pfizer is conducting a Phase 1 study of PF-07934040 in adults with advanced solid tumors carrying a genetic mutation, evaluating the drug alone or with other an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• PF-07934040

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms | Phase 1 | Status: RECRUITING